The Government Is Keeping Almost All of Abbott's $385 Million Formula Settlement. The Families of the Dead Infants Get Nothing.

I read the settlement figure twice before it sank in. Abbott agreed to pay $385 million over the Sturgis, Michigan plant at the center of the contamination investigation, the one tied to two infant deaths, and for about ten seconds I felt something like relief. Somebody was finally paying. Then I read where the money actually goes, and the relief drained right out of me. Almost none of it is for the families.

Of that $385 million, $348.7 million goes to the federal government and $36.3 million goes to states for their Medicaid and WIC programs. Read that split again. This is a False Claims Act settlement, which means it is not compensation for two dead babies. It is Washington getting reimbursed because Abbott sold formula produced in a risky plant through federally funded nutrition programs. The food-safety attorney Bill Marler put it more plainly than any press release would: Abbott is paying “$384,999,040 for the Formula It Sold WIC.” The government made itself whole. The grieving parents were not part of the deal.

There is one more number that stuck in my throat. Of that settlement, $69 million goes to three former Abbott employees, the whistleblowers who filed the case. I am glad they are protected, I mean that. But look at the order of who gets made whole. The whistleblowers collect $69 million. The government collects its reimbursement. The families of the infants who died collect nothing from this settlement. And Abbott admits to none of it: the deal, the company says, “does not represent any finding of fault or liability,” and the DOJ notes the claims are “allegations only.”

Roof leaks, cracked dryers, and a decision not to test

The comforting version of this story is simple. A giant company wrote a nine-figure check, so the system worked. Now read what the government’s own complaint describes. The Justice Department alleged that roof leaks were a common occurrence at the Sturgis plant, with water running and dripping over equipment, and that instead of fixing the cause Abbott used temporary measures, including “roof leak umbrellas,” to divert it. It alleged the company kept running its spray dryers, the machines that turn liquid formula into powder, even after documenting cracks and pits inside them. And this is the allegation I keep rereading: that Abbott “intentionally did not test for bacterial growth to avoid obtaining positive test results showing contamination.” A wet building, cracked equipment, and a deliberate choice not to look, all at the largest infant-formula factory in the country.

The workers saw it coming. In October 2021, a former quality employee sent the FDA a 34-page report alleging Abbott falsified records, tested the seals on empty cans rather than sealed product, released formula after microorganisms turned up, and did not recall product even after management knew of a nonconformity. It also described efforts to keep FDA auditors from learning what was happening. Reports of infected infants had started arriving around September 2021. The FDA did not interview the whistleblower until late December, and did not begin its on-site inspection until January 31, 2022. Frank Yiannas, then the FDA’s deputy commissioner for food, later told Congress the whole episode was a “preventable tragedy” and that acting faster “could have averted this crisis.” Four months passed while the reports came in. Two infants died, and at least two more were hospitalized.

The one bug that survives being dried out

I wanted to understand why these specific conditions, in this specific product, are so dangerous, so I went into the biology. The answer unsettled me.

The organism is Cronobacter sakazakii, and it has a trick most bacteria don’t: it survives being dried out. Pasteurization kills it. But formula gets some of its heat-sensitive nutrients added after that heat step, and that is exactly when a hardy environmental bug can slip into the powder, which is why researchers flag the post-pasteurization stage as the vulnerable one for Cronobacter. So when it shows up in a sealed can, it usually did not ride in with the milk. It came from the building. And once it is in the powder it doesn’t die off, it waits, desiccation-hardened, for someone to add warm water.

Now think about who that powder is for. In a healthy adult, Cronobacter usually causes little or nothing. In a newborn, especially one under two months or born premature, it can cross into the bloodstream and the brain. Why would an organism this obscure be so lethal to a two-week-old? Because a newborn’s gut lining is still leaky and its immune system hasn’t met the world yet, so a dose an adult would clear finds an open door. The CDC reports that Cronobacter meningitis kills nearly 40 percent of the infants who develop it, and many survivors are left with lasting neurological damage. A leaky roof over cracked dryers is not a paperwork problem, then. It is close to the exact recipe for letting a drying-proof, infant-seeking pathogen ride a sealed can into a nursery.

I want to be honest about what the record does not show, because the documented failures are damning without stretching them. The Cronobacter strains found in Abbott’s product did not genetically match the strains from the sick infants, and the company says no unopened, distributed formula ever tested positive. That gap matters, and it is Abbott’s entire defense. It does not erase the roof leaks, the cracked dryers, the choice not to test, or the four months the FDA let slip. Those are on the record. What a no-fault settlement guarantees is that the rest of the accounting never happens.

The half-million-dollar question

Here is where I stop being able to explain it with biology. In 2023, the DOJ opened a criminal case against Abbott. In June 2026, it closed that case, with a department spokeswoman saying criminal charges “would have been heavy handed” and that “this Department of Justice does not believe in regulation by prosecution.”

Consider the sequence around that decision. Abbott gave $500,000 to the presidential inaugural fund, and reporting shows the president personally bought roughly $500,000 in Abbott stock over 2025, while the criminal case was still open. Then the case went away, replaced by a civil settlement that reimburses the government and lets the company admit nothing. No prosecutor or court has established that the money bought the outcome, and I am not going to claim one did. But you do not need a proven quid pro quo to see the shape of it.

I will say this plainly, because health-populism does not run on loyalty to any politician: this is exactly the kind of corporate capture the MAHA movement promised to tear down, and here it is under an administration that ran on doing the tearing. A company runs a plant with leaking roofs and cracked dryers, a slow FDA sits on a whistleblower’s warning for four months, two babies die, and the resolution is a check written to Washington and a criminal file closed after the donations flowed the other way. Changing which party holds the pen did not change the ink. The families are still standing outside the room where the money moves.

So what do I take from this, as a person and not a byline? I take the biology seriously in my own kitchen, because on this record the institutions will not do it for me. The CDC’s own advice for the most vulnerable babies is blunt: for infants under two months, premature, or immune-compromised, it says to consider alternatives to powdered formula altogether, like sterile ready-to-feed liquid, and to prepare any powder with real care. It is a small, ownable act. It also should not fall to me. I am being asked to perform, at my own sink, the seriousness a company worth billions and its regulator would not. If I had a newborn that small, I would reach for the ready-to-feed liquid and stop treating powdered formula as automatically safe. I would not wait for the recall, the settlement, or the apology. On this record, the apology is the one thing that is never coming.

Sources

1. U.S. Department of Justice – Abbott Agrees to Pay Over $384M to Settle Allegations Related to Contaminated Infant Formula (2026)
2. STAT – Abbott agrees to $385M settlement over closure of largest U.S. baby formula plant (2026)
3. MedPage Today – Abbott agrees to settlement over Sturgis formula plant closure (2026)
4. Marler Blog – “500,000 Reasons to Drop a Criminal Investigation”
5. Food Safety Magazine – Trump Admin stopped criminal charges against Abbott Nutrition
6. Food Safety News – Former employee blows whistle on Abbott formula plant (2022)
7. U.S. House Committee on Oversight – Former FDA official: infant formula crisis was “a preventable tragedy”
8. CDC MMWR – Cronobacter sakazakii Infections in Two Infants Linked to Powdered Infant Formula (2023)
9. FDA – Strategy to help prevent Cronobacter sakazakii illnesses from powdered infant formula
10. Frontiers in Microbiology – Pathogen inactivation during reconstitution of powdered infant formula (2026)